Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $128.87
Change -$1.01 | -0.78%
As Of 9/30/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.

Net Asset Value

Net Asset Value $128.87
Change -$1.01 | -0.78%


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Volume 14,181
Last Sale Price $129.05
52-Week Range $131.61 / $100.09
Shares Outstanding 2,600,000
Total Net Assets $335,072,616.28

Market Close

Market Price $129.05
Premium / Discount $0.18
Change -$0.89 | -0.68%
High / Low $130.73 / $128.89

Historical Market Closes to NAV

  Days % of Total Days
Premium 977 49.10%
Discount 905 45.48%
Equal to NAV 108 5.43%
Total 1,990 100%


Number of Stocks 55
Return on Equity (quarterly 9/30/14) 17.87%
Price to Earning (P/E) 24.53
Price to Book (P/B) 3.61
Dividend Amount $0.14
Ex-Dividend Date N/A


As of 9/30/14
Standard Deviation Sharpe Ratio Beta R-Squared
10.60 N/A 1.03 99.41

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.


as of 9/30/2014
Total Assets $335,072,616
Number of Stocks 55
Percent Stock 99.81%
Percent Cash / Other 0.19%

Sectors / Industries

as of 9/30/14


as of 9/30/14

Security Name Ticker Shares
% of Net Assets Sector / Industry
VERTEX PHARMACEUTICALS VRTX 65,663 $7,374,611.53 2.20% Biotechnology
ALLERGAN INC AGN 36,077 $6,428,560.63 1.92% Pharmaceuticals
MALLINCKRODT PLC MNK 70,795 $6,382,169.25 1.90% Pharmaceuticals
REGENERON PHARMACEUTICALS REGN 17,644 $6,361,014.88 1.90% Biotechnology
PERRIGO COMPANY PRGO 42,257 $6,346,578.83 1.89% Pharmaceuticals
CELGENE CORPORATION CELG 66,719 $6,323,626.82 1.89% Biotechnology
ACTAVIS PLC ACT 26,052 $6,285,826.56 1.88% Pharmaceuticals
GILEAD SCIENCES, INC. GILD 58,904 $6,270,330.80 1.87% Biotechnology
EDWARDS LIFESCIENCES CORP EW 61,257 $6,257,402.55 1.87% Health Care Equipment & Supplies
BIOGEN IDEC, INC. BIIB 18,881 $6,246,023.61 1.86% Biotechnology
ZOETIS INC ZTS 168,769 $6,236,014.55 1.86% Pharmaceuticals
PATTERSON COS INC PDCO 150,508 $6,235,546.44 1.86% Health Care Providers & Services
JOHNSON & JOHNSON JNJ 58,386 $6,223,363.74 1.86% Pharmaceuticals
ALEXION PHARMACEUTICALS I ALXN 37,525 $6,222,395.50 1.86% Biotechnology
AMGEN INC. AMGN 44,282 $6,219,849.72 1.86% Biotechnology
BRISTOL MYERS SQUIBB CO BMY 121,490 $6,217,858.20 1.86% Pharmaceuticals
HUMANA, INC. HUM 47,607 $6,202,716.03 1.85% Health Care Providers & Services
CERNER CORPORATION CERN 103,933 $6,191,288.81 1.85% Health Care Technology
MCKESSON CORPORATION MCK 31,726 $6,176,100.42 1.84% Health Care Providers & Services
WELLPOINT, INC. WLP 51,476 $6,157,559.12 1.84% Health Care Providers & Services
PFIZER INC PFE 207,478 $6,135,124.46 1.83% Pharmaceuticals
AMERISOURCEBERGEN CORP ABC 79,197 $6,121,928.10 1.83% Health Care Providers & Services
BECTON DICKINSON & CO BDX 53,699 $6,111,483.19 1.82% Health Care Equipment & Supplies
UNITEDHEALTH GROUP INC. UNH 70,852 $6,110,985.00 1.82% Health Care Providers & Services
ABBVIE INC-W/I ABBV 105,496 $6,093,448.96 1.82% Pharmaceuticals
MERCK & COMPANY, INC. MRK 102,537 $6,078,393.36 1.81% Pharmaceuticals
CARDINAL HEALTH, INC. CAH 80,993 $6,067,995.56 1.81% Health Care Providers & Services
ELI LILLY & COMPANY LLY 93,551 $6,066,782.35 1.81% Pharmaceuticals
HOSPIRA INC HSP 116,019 $6,036,468.57 1.80% Pharmaceuticals
DAVITA, INC DVA 82,436 $6,029,369.04 1.80% Health Care Providers & Services
THERMO FISHER SCIENTIFIC TMO 49,530 $6,027,801.00 1.80% Life Sciences Tools & Services
AETNA INC AET 74,283 $6,016,923.00 1.80% Health Care Providers & Services
CIGNA CORPORATION CI 66,140 $5,998,236.60 1.79% Health Care Providers & Services
ABBOTT LABORATORIES ABT 143,504 $5,968,331.36 1.78% Health Care Equipment & Supplies
PERKINELMER PKI 136,693 $5,959,814.80 1.78% Life Sciences Tools & Services
CAREFUSION CORP CFN 131,624 $5,955,986.00 1.78% Health Care Equipment & Supplies
DENTSPLY INTERNATIONAL XRAY 130,611 $5,955,861.60 1.78% Health Care Equipment & Supplies
WATERS CORPORATION WAT 59,993 $5,946,506.16 1.77% Life Sciences Tools & Services
AGILENT TECHNOLOGIES, INC A 104,199 $5,937,259.02 1.77% Life Sciences Tools & Services
QUEST DIAGNOSTICS, INC. DGX 97,510 $5,916,906.80 1.77% Health Care Providers & Services
STRYKER CORP SYK 73,162 $5,907,831.50 1.76% Health Care Equipment & Supplies
MYLAN INC. MYL 129,751 $5,902,372.99 1.76% Pharmaceuticals
TENET HEALTHCARE CORP THC 99,239 $5,893,804.21 1.76% Health Care Providers & Services
C.R. BARD, INC. BCR 41,277 $5,890,640.67 1.76% Health Care Equipment & Supplies
BAXTER INTERNATIONAL BAX 81,742 $5,866,623.34 1.75% Health Care Equipment & Supplies
INTUITIVE SURGICAL, INC. ISRG 12,701 $5,865,575.82 1.75% Health Care Equipment & Supplies
ZIMMER HOLDINGS INC ZMH 58,186 $5,850,602.30 1.75% Health Care Equipment & Supplies
EXPRESS SCRIPTS HLDGS ESRX 82,811 $5,848,940.93 1.75% Health Care Providers & Services
LABORATORY CORP OF AMERIC LH 57,415 $5,841,976.25 1.74% Health Care Providers & Services
COVIDIEN PLC COV 67,344 $5,825,929.44 1.74% Health Care Equipment & Supplies
ST. JUDE MEDICAL INC. STJ 96,798 $5,820,463.74 1.74% Health Care Equipment & Supplies
MEDTRONIC, INC. MDT 93,666 $5,802,608.70 1.73% Health Care Equipment & Supplies
BOSTON SCIENTIFIC CORP BSX 488,486 $5,769,019.66 1.72% Health Care Equipment & Supplies
VARIAN MEDICAL SYSTEMS IN VAR 71,559 $5,733,307.08 1.71% Health Care Equipment & Supplies
UNIVERSAL HEALTH SERVICES UHS 54,660 $5,711,970.00 1.70% Health Care Providers & Services


Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

2014 Guggenheim Investments. All Rights Reserved.
• Not FDIC Insured • No Bank Guarantee • May Lose Value